Simplified HPLC Method for the Determination of Prazosin in Human Plasma and Its Application to Single-dose Pharmacokinetics

  • Published : 2005.06.01

Abstract

Prazosin hydrochloride is an antihypertensive drug with selective ${\alpha}_1$-adrenoreceptor blocking effects. A simple high performance liquid chromatographic method has been developed and validated for the quantitative determination of prazosin in human plasma. A reversed-phase C18 column was used for the separation of prazosin and terazosin (internal standard) with a mobile phase composed of water, acetonitrile and triethylamine(75:25:0.1, V/V;pH5.0) at a flow rate of 1.5 ml/min. the fluorescence detector was set at excitation and emissionwavelengths of 250 and 370 nm, respectively. Intra-and inter-day precision and accuracy were acceptable for all quality control samples including the lower limit of quantification of 0.5 ng/ml. Good recovery (>80%) was seen in plasma. Prazosin was stable in human plasma under various storage conditions. This method was used successfully for a pharmacokinetic study in plasma after oral administration of a single 2-mg dose as prazosin base to 16 healthy volunteers. The maximum plasma concentration of prazosin was 23.1 ${\pm}$ 16.5 ng/ml at 2.1 h, and the mean area under the curve and elimination half-life were calculated to be 108.4 ${\pm}$ 74.2 ng ${\cdot}$hr/ml and 2.5 ${\pm}$ 0.6 h, respectively.

Keywords

References

  1. Akduman, B. and Crawford, E. D. (2001). Terazosin, doxazosin and prazosin: current clinical experience. Urology 58, 49-54 https://doi.org/10.1016/S0090-4295(01)01302-4
  2. Cheah, P. Y., Yuen, K. H. and Liong, M. L. (2000). Improved high-performance liquid chromatographic analysis of terazosin in human plasma. J Chromatogr. B. Biomed. Sci. Appl. 745, 439-443 https://doi.org/10.1016/S0378-4347(00)00313-3
  3. Cho, E. S., Kang, S. H. and Chun, I. K. (2002). Determination of terazosin in human plasma by liquid chromatography and bioequivalence study of teratonin tablets. J Kor. Pharm. Sci. 32, 119-125
  4. Constantine, J. W. (1975). Analysis of the hypotensive actions of prazosin. Postgrad. Med. Spec No, 18-35
  5. Food and Drug Administration, Guidance for Industry: Bioanalytical method validation, Center for Drug Evaluation and Research, Rockville, MD, 2001
  6. Hess, H. J. (1975). Prazosin: biochemistry and structure-activity studies with prazosin. Postgrad. Med. Spec No, 9-17
  7. Hobbes, D. C., Twomey, T. M. and Palmer, R. F. (1978). Pharmacokinetics of prazosin in man. J Clin. Pharmacal. 18, 402-406 https://doi.org/10.1002/j.1552-4604.1978.tb02456.x
  8. Kamas, H. T., Shiu, G. and Shah, V. P. (1991). Validation of bioanalytical methods. Pharm. Res. 8, 421-426 https://doi.org/10.1023/A:1015882607690
  9. Kang, B. C., Yang, C. Q., Rhee, J. E., Suh, O. K. and Shin, W. G. (2001). High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers. Res. Cammun. Mal. Pathal. Pharmacal. 110, 371-377
  10. Patterson, S. E. (1985). Terazosin kinetics after oral and intravenous doses. Clin. Pharmacal. Ther. 38, 423-427 https://doi.org/10.1038/clpt.1985.198
  11. Rathinavelu, A. and Malave, A. (1995). High-performance liquid chromatography using electrochemical detection for the determination of prazosin in biological samples. J Chromatogr. B. Biomed. Sci. Appl. 670, 177-182 https://doi.org/10.1016/0378-4347(95)00139-A
  12. Sekhar, B. C., Rao, T. R., Sekhar, K. R., Naidu, M. U., Shobha, J. C., Rani, P. U., Kumar, T. V. and Kumar, V. P. (1998). Determination of terazosin in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatogr. B. Biomed. Sci. Appl. 710, 137-142 https://doi.org/10.1016/S0378-4347(98)00120-0
  13. Vincent, J., Meredith, P. A., Reid, J. L., Elliott, H. L. and Rubin, P. C. (1985). Clinical pharmacokinetics of prazosin. Clin. Pharmacokinet. 10. 144-154 https://doi.org/10.2165/00003088-198510020-00002